Navigation Links
Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions
Date:11/9/2010

ENGLEWOOD, Colo., Nov. 9, 2010 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today introduced the ExactaMix 1200 Automated Compounding Device (ACD) for small- to mid-sized hospital pharmacies in need of an automated approach to compounding large-volume parenteral doses.  The entry-level 12-port compounder extends the market-proven Baxa ExactaMix Product Line and brings delivery precision and safe handling to pharmacies that want the compounding safety and efficiency that automation offers, but don't require the full range of the ExactaMix 2400 Compounder's capabilities.  The new ExactaMix 1200 will be exhibited next month at the 2010 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting (MCM) & Exhibition.

The ExactaMix products automatically compound sterile doses, minimizing the risk of measurement errors, wrong drug selection, touch contamination and patient infection in the preparation of solutions for TPN, cardioplegia, dialysis and epidural delivery.  Capable of volumes as low as 0.2 mL, the new ExactaMix 1200 safely and accurately delivers both micro and macro ingredients. The ExactaMix 1200 and ExactaMix 2400 are the only ACDs with both volumetric delivery and gravimetric check, enabling pharmacists to ensure accuracy with both volume and fill data.

State-of-the-art Baxa compounding technology delivers final bag accuracies within +/- 4% with barcode ingredient verification, and pumps a typical three-liter nutrition bag in approximately 3.5 minutes -- nearly two times faster than industry average.  Its features improve compounding efficiency, enabling pharmacy professionals to focus on patient care with the confidence that safety, regulatory compliance and preparation accuracy goals are met.

"The ExactaMix 1200 dispels the myth that only large healthcare facilities and hospitals can take advantage of the safety and efficiency of proven, cutting-edge automated compounding technology," said Laura Zoerner, Senior Product Manager at Baxa Corporation.  "With the addition of the 12-port compounder, we now offer a wider range of solutions with globally recognized ExactaMix Technology. Now virtually any hospital can afford automated compounding for therapies such as TPN, cardioplegia and dialysis and epidural solutions to achieve both accuracy and speed -- while maintaining USP <797> compliance and delivering exactly right doses."

In its 45th year, the MCM takes place December 5 – 9, 2010 at the Anaheim Convention Center in Anaheim, California.  In addition to ExactaMix 1200, Baxa will showcase its extensive line of solutions that efficiently and safely deliver more than 450,000 doses each day, including its DoseEdge™ Pharmacy Workflow Management System.  Over 5 million doses have been processed by DoseEdge in US hospitals to date.  DoseEdge has prevented more than 100,000 preparation errors through barcode verification of every ingredient drug and best-practice compounding process management.  To view technical videos or download educational materials on FormularyPlus enhancements for DoseEdge, visit www.baxa.com/doseedge.

Baxa Corporation reliably and consistently enables pharmacists at more than 3,000 hospitals worldwide to safely prepare and administer intravenous therapies.  To learn more about the ExactaMix 1200, visit www.baxa.com/exactamix.  For additional information, to request a product brochure or download a free, educational white paper, visit www.baxa.com, call 800-567-2292 or email info@baxa.com.

About Baxa CorporationBaxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery.  Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications.  Key products include the Abacus® Order Entry and Calculation Software, the DoseEdge™ Pharmacy Workflow Manager, ExactaMed® Oral Syringes, ExactaMix™ Automated Compounding Devices, InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock®  Set Saver and the RapidFill™ Automated Syringe Filler; used worldwide in hospitals and healthcare facilities.  Its subsidiary FHT, Inc. produces the IntelliFill® i.v. automation.  Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide.  Further information is available at www.baxa.com.Contact:Marian Robinson, Vice President, MarketingBaxa Corporation:  800.567.2292 ext. 2157 or 303.617.2157Email:  marian.robinson@baxa.comPerrin McCormick or Brandie GerrishHart-Boillot: 781-893-0053Email: baxa@hartboillot.com
'/>"/>

SOURCE Baxa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
(Date:6/24/2016)... Arizona (PRWEB) , ... June 24, 2016 , ... ... practice, is supporting the upcoming 2016 Miss Arizona pageant as its official Medspa ... serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says the ...
Breaking Medicine News(10 mins):